Beijing Mygenostics Co., Ltd. is a leading high-tech biotechnology manufacturer and service provider established in 2011. Headquartered in Beijing with a 10,000-square-meter research and medical laboratory facility, the company also operates a wholly-owned subsidiary in Chongqing. With a workforce of over 750 employees, Mygenostics specializes in the R&D, production, and marketing of molecular diagnostics products, IVD devices, and comprehensive genomic solutions. The company is recognized for its patented GenCap™ technology, which enhances next-generation sequencing (NGS) by capturing both strands of genomic target regions to improve accuracy and reduce costs.
Their extensive product portfolio includes automated liquid handlers, nucleic acid extraction systems and kits, PCR kits, and specimen collection solutions. They also provide automated pipetting systems, microplate washers, and laboratory plastics. Mygenostics serves the scientific research, clinical, and diagnostic industries, offering OEM services and technical support. The company maintains high quality standards with ISO 13485 and FSC certifications. Since 2021, they have expanded their international trade footprint, exporting to Europe, the Middle East, South America, Africa, and Southeast Asia. Their technical excellence is supported by collaborations with prestigious universities and hospitals globally, contributing to over 450 scientific research papers and conducting more than 170,000 clinical tests.
C&G Biotech Limited is a specialized manufacturer and service provider based in Hong Kong, established in 2008. The company operates as a contract manufacturer and raw material supplier for the In-Vitro Diagnostic (IVD) industry, maintaining a workforce of 11 to 50 employees. Their core product portfolio includes high-quality antigens, antibodies, and uncut sheets designed for use in rapid tests, ELISA, and chemiluminescence assays. C&G Biotech Limited is particularly noted for its production of Dengue Ns1 and NT-proBNP uncut sheets, which are engineered to help clients reduce manufacturing costs while maintaining high diagnostic standards. Beyond raw materials, the company leverages its proximity to clinical environments to provide IVD manufacturers with essential positive samples, including HIV, HCV, TP, HBV, and TB, for rigorous testing and validation. To support both startups and established firms, they offer comprehensive technical training aimed at assisting clients in establishing their own high-quality rapid test manufacturing lines. The company operates with a commitment to quality and reliability, backed by a factory and certifications including ISO 9001, ISO 13485, and GMP standards. Their mission focuses on delivering competitive pricing and consistent lot-to-lot quality for lateral flow reagents globally.